Physician profile
Benjamin Bonner
NPI 1831698364
$7,481.85
in general payments reported to CMS, 2019-2025
14 companies · $554 in 2025
The $554 reported for 2025 was less than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,212 · 2022: $2,840 · 2023: $1,001 · 2024: $1,875 · 2025: $554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,031 · Travel and Lodging: $399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,030.54 |
| Travel and Lodging | $399.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mid-Atlantic Surgical Systems, LLC | $2,557.28 | 2021-2022 | |
| Stryker Corporation | $1,859.41 | 2022-2025 | Pro, Mako, T2 Alpha |
| Arthrex, INC. | $1,013.00 | 2022 | |
| Si-Bone, INC. | $452.34 | 2023-2024 | |
| Zimmer Biomet Holdings, INC. | $368.53 | 2024 | Affixus, Ribfix Blu Advantage, Arcos |
| Depuy Synthes Sales INC. | $360.53 | 2024 | Na, Fibergraft Bg Morsels, Motoband Cp |
| Titan Surgical Group, LLC | $309.38 | 2024 | |
| Curvafix, INC. | $134.38 | 2025 | Curvafix Im Implant |
| Kerecis Limited | $126.44 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Pacira Pharmaceuticals Incorporated | $122.93 | 2024 | Exparel |
| Skeletal Dynamics INC | $116.45 | 2024 | Geminus, Ijs, Align |
| Vertex Pharmaceuticals Incorporated | $21.11 | 2025 | |
| Cdc Medical LLC | $20.50 | 2024 | |
| Solventum Corporation | $19.57 | 2025 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Bonner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.